Luís Alberto de Pádua Covas Lage

Author

Also Known As

J. Luís Alberto de Pádua Covas Lage, L. A. P. C Lage, L. Valente Lage, Lage LAPC, Lage, Luis Alberto De Padua Covas, Luciana Ferreira Stahel Lage, Luis A. P. C. Lage, Luis A.P.C. Lage, Luis Alberto C. Lage, Luis Alberto De Padua Covas Lage

Publications

290

Citations

H-Index

Concepts

All Affiliations

Universidade de São Paulo Churchill Hospital Centro Universitário Lusíada University of Oxford Fundação Pró-Sangue Hemocentro de São Paulo

About

Luís Alberto de Pádua Covas Lage is an author at Universidade de São Paulo specializing in oncology, pathology, and tumor immunity.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	15
2	Immunology	1	1	15
3	Pathology	1	1	15
4	Autoimmunity	1	1	15
5	Immunotherapy	1	1	15

Luís Alberto de Pádua Covas Lage

Publications

Citations

H-Index

Page 1

	Year	Citations
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms Xiangrong Geng, Chenguang Wang, Xin Gao, Blood Cancer Journal	2022	30
Interim fluorine-18 fluorodeoxyglucose PET-computed tomography and cell of origin by immunohistochemistry predicts progression-free and overall survival in diffuse large B-cell lymphoma patients in the rituximab era Renata de Oliveira Costa, Abrahão Hallack Neto, Sheila Aparecida Coelho Siqueira, Nuclear Medicine Communications	2016	21
Primary nodal peripheral T-cell lymphomas: diagnosis and therapeutic considerations Luís Alberto de Pádua Covas Lage, Tamara Carvalho dos Santos Cabral, Renata de Oliveira Costa, Revista Brasileira de Hematologia e Hemoterapia ImmunologyPathologyImmunotherapyTumor BiologyHematological Malignancy	2015	15
Bone marrow necrosis: literature review Tamara C. S. Cabral, Carolina M. Fernandes, Luís Alberto de Pádua Covas Lage, Jornal Brasileiro de Patologia e Medicina Laboratorial	2016	11
New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL) Diego Reis, Débora Levy, Luís Alberto de Pádua Covas Lage, Brain and Behavior	2021	10
TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients Luís Alberto de Pádua Covas Lage, Guilherme Carneiro Barreto, Hebert Fabrício Culler, Cancer Biomarkers	2022	10

Page 1